Pfeiffer Vacuum Technology O.N. (PFV)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 163.00 |
|---|---|
| 52-week range | 154.20 – 173.80 |
| Return, 1 month / 3 months | −0.6% / −0.4% |
| Return, 1 year / 3 years | +9.9% / +28.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 34 |
| Volatility (1 year) | 6.3% |
| Worst drawdown (1 year) | -3.0% |
| Average daily value traded | 0.41M EUR |
| Dividend yield | 4.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Pfeiffer Vacuum Technology makes vacuum pumps and related equipment, including turbomolecular pumps, rotary vane pumps, gauges, leak detectors and mass spectrometers. Its customers are industrial firms and research laboratories that need controlled vacuum conditions, such as semiconductor manufacturers, coating plants, analytical instrument makers and universities. The company is based in Germany and supplies its products and services to customers around the world.
The shares are listed on the XETRA Stock Exchange in Germany under the code PFV, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Pfeiffer Vacuum Technology O.N. (PFV) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 163.00 on 23 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 71 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 9.9% and over the last three months it fell 0.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.0% | ||
| From 52-week high | -5.6% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.4% | ||
| 6-month return | 1.7% | ||
| 12-month return, skipping the last month | 10.5% | ||
| Stability (higher is calmer) | 100 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 6.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -3.0% | ||
| Liquidity | 63 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.41M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.5% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.6% |
|---|---|
| 1 month | −0.6% |
| 3 months | −0.4% |
| 6 months | +1.7% |
| 1 year | +9.9% |
| 3 years | +28.7% |
| 5 years | +0.3% |
Signals
| 50-day / 200-day average | 165.01 / 161.44 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.82 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Jul 2026 | EUR 7.3200 |
| 3 Jul 2025 | EUR 7.9300 |
| 8 Jul 2024 | EUR 7.3200 |
| 3 May 2023 | EUR 0.1100 |
| 20 May 2022 | EUR 4.0800 |
| 13 May 2021 | EUR 1.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.